New edited immune cell therapy helps patients beat aggressive blood cancer
BBC - 09-Dec-2025This approach may help people whose cancer does not respond to standard care
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
This approach may help people whose cancer does not respond to standard care
First-line nivolumab doubles typical response rates in inoperable basal cell carcinoma
Jab targeting KRAS mutation kept some patients cancer-free for over 15 months
New dual-bacteria therapy shows potent, safe cancer-killing power in immunocompromised models
AI tool finds hidden immune cell types to improve cancer diagnosis and targeted therapies
Click on resource name for more details.
Biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies
Company that develops products to help patients on dialysis, and on other extra-corporeal treatments
No blog posts found!